argenx SE | ARGX - Sales Revenues

Stock Price
616.00
Daily Change
-0.80 -0.13%
Monthly
-13.77%
Yearly
9.03%
Q1 Forecast
598.33

argenx SE reported $1.12B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
AstraZeneca USD 15.5B 313M Dec/2025
Galapagos EUR 900.82M 835.52M Dec/2025
Genmab DKK 5.86B 580M Jun/2025
GlaxoSmithKline GBP 8.62B 73M Dec/2025
GRIFOLS EUR 1.98B 110M Dec/2025
Hikma Pharmaceutical USD 1.69B 863M Dec/2025
Qiagen NV USD 457.38M 6.06M Dec/2025
UCB EUR 3.49B 129M Jun/2025